Scott L. Burrows

Business address
C/O Spyre Therapeutics, Inc., 221 Crescent Street, Suite 105, Waltham, MA, 02453
Top holdings (ownership)
SYRE and ARQT
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Scott L. Burrows has filed 18 SEC EDGAR filings since 05 Apr 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 03 Sep 2025 02 Sep 2025 001-37722
4 Open Document Open Filing FORM 4 17 Jan 2025 15 Jan 2025 001-37722
4 Open Document Open Filing FORM 4 05 Sep 2024 03 Sep 2024 001-37722
4 Open Document Open Filing 4 02 Feb 2024 01 Feb 2024 001-37722
4 Open Document Open Filing 4 22 Dec 2023 22 Dec 2023 001-37722
144 Open Document Open Filing 29 Nov 2023
4 Open Document Open Filing 4 05 Sep 2023 01 Sep 2023 001-37722
3 Open Document Open Filing 3 05 Sep 2023 01 Sep 2023 001-37722
4 Open Document Open Filing FORM 4 08 Mar 2023 06 Mar 2023 001-39186
4 Open Document Open Filing FORM 4 06 Mar 2023 02 Mar 2023 001-39186
4 Open Document Open Filing FORM 4 02 Mar 2023 28 Feb 2023 001-39186
4 Open Document Open Filing FORM 4 20 Sep 2022 16 Sep 2022 001-39186
4 Open Document Open Filing FORM 4 07 Mar 2022 03 Mar 2022 001-39186
4 Open Document Open Filing FORM 4 03 Mar 2022 01 Mar 2022 001-39186
4 Open Document Open Filing FORM 4 04 Jan 2022 30 Dec 2021 001-39186
4 Open Document Open Filing FORM 4 SUBMISSION 28 Dec 2021 27 Dec 2021 001-39186
4 Open Document Open Filing FORM 4 05 Apr 2021 01 Apr 2021 001-39186
3 Open Document Open Filing FORM 3 05 Apr 2021 01 Apr 2021 001-39186